<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01914952</url>
  </required_header>
  <id_info>
    <org_study_id>MTI2013-CS02</org_study_id>
    <nct_id>NCT01914952</nct_id>
  </id_info>
  <brief_title>Alternate Dosing Strategies for Beta-hydroxy-beta-methylbutyrate (HMB) Supplementation: Effect on Plasma HMB Responses</brief_title>
  <official_title>Alternate Dosing Strategies for Beta-hydroxy-beta-methylbutyrate (HMB) Supplementation: Effect on Plasma HMB Responses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Metabolic Technologies Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Metabolic Technologies Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the rise in plasma Beta-hydroxy-beta-methylbutyrate
      (HMB) after the dietary supplement has been administered in different forms. Prior studies
      have indicated that form of administration affects bioavailability of the HMB supplement.
      Therefore the current study will examine the bioavailability of a single dose of HMB given
      as:

        -  1.0g CaHMB in gelatin capsule

        -  0.8 g HMB free acid in a gelcap

        -  0.8 g HMB free acid in water

        -  1.0 g CaHMB in water

        -  0.8 g HMB free acid

      The randomized study will be a crossover design and each study subject will undergo the
      experimental protocol for each of the supplementation forms. Because of the different
      administration forms, the study will be an open label study. Briefly, the fasted participants
      will report to the laboratory in the morning. After an initial blood sample is taken, the
      dose of HMB will be administered. Blood will then be samples at 2, 5, 10, 15, 25, 35, 45, 60,
      90, 120, 180, 360, 720, and 1440 min post administration. A 24 h complete urine collection
      will also be performed. Participants will be given a light sack lunch 4 h after
      administration of the dosage and will remain at the laboratory through the 360 min sampling.
      Participants will then be allowed to leave the laboratory and return for the 720 min sampling
      after which the participants can eat an normal evening meal. Participants will return to the
      laboratory fasted the next morning for the final sample. A minimum 48 h washout period will
      be required before the next dosage form is administered and the process repeated.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">May 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma HMB Level</measure>
    <time_frame>Plasma samples collected at 0, 2, 5, 10, 15, 25, 35, 45, 60, 90, 120, 180, 360, 720, and 1440 min after treatment administration</time_frame>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Focus of the Study is to Examine Plasma HMB Levels After Oral HMB Supplementation</condition>
  <arm_group>
    <arm_group_label>CaHMB Capsule</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>HMB free acid gelcap</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>HMB free acid in water</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>CaHMB powder in water</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>HMB free acid (oral not in gelcap or water)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>CaHMB capsule</intervention_name>
    <description>1.0 gram of CaHMB powder in a gelatin capsule</description>
    <arm_group_label>CaHMB Capsule</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>HMB free acid gelcap</intervention_name>
    <description>0.8 g HMB free acid is a soft gel capsule</description>
    <arm_group_label>HMB free acid gelcap</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>HMB free acid mixed in water</intervention_name>
    <description>0.8 g HMB free acid in water</description>
    <arm_group_label>HMB free acid in water</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>CaHMB in water</intervention_name>
    <description>1.0 g CaHMB powder mixed in water</description>
    <arm_group_label>CaHMB powder in water</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>HMB free acid</intervention_name>
    <description>0.8 g HMB free acid</description>
    <arm_group_label>HMB free acid (oral not in gelcap or water)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must not be taking amino acid, protein, or HMB supplements; Must not be pregnant; Must
             not be breastfeeding

        Exclusion Criteria:

          -  Currently taking amino acid, protein, or HMB supplements; Currently pregnant;
             Currently breastfeeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Iowa State University</name>
      <address>
        <city>Ames</city>
        <state>Iowa</state>
        <zip>50014</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 31, 2013</study_first_submitted>
  <study_first_submitted_qc>August 1, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 2, 2013</study_first_posted>
  <last_update_submitted>September 15, 2014</last_update_submitted>
  <last_update_submitted_qc>September 15, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 16, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CaHMB</keyword>
  <keyword>HMB free acid</keyword>
  <keyword>HMB</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

